Search

everythinglearnresearchcommunity

for

Search:↓

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Potassium iodide prevents hair loss and reduces toxicity from thallium acetate.

Nanoemulsions can effectively deliver antiseptic agents deep into the skin.

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Erlotinib can cause hair loss as a side effect.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

One child resisted treatment, while the other was successfully treated for scalp ringworm.

Transethosomal gels improve naftifine skin delivery better than Exoderil cream.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

Tinea capitis is a common scalp infection in children, treated with antifungal medications like griseofulvin, terbinafine, and fluconazole.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Medium-depth peels are safer and effective for improving skin appearance compared to deep peels.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Dithranol is more effective than Tacrolimus for hair regrowth in alopecia areata.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.